ID   ATG2A-B-KO HeLa
AC   CVCL_F1ZL
SY   ATG2A-B KO; Human ATG2A/B knockout HeLa
RX   PubMed=34799570;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 31-03-26; Last updated: 31-03-26; Version: 1
//
RX   PubMed=34799570; DOI=10.1038/s41467-021-26999-x; PMCID=PMC8605025;
RA   Mailler, Elodie
RA   Guardia, Carlos M.
RA   Bai, Xiaofei
RA   Jarnik, Michal
RA   Williamson, Chad D.
RA   Li, Yan
RA   Maio, Nunziata
RA   Golden, Andy
RA   Bonifacino, Juan S.
RT   "The autophagy protein ATG9A enables lipid mobilization from lipid
RT   droplets.";
RL   Nat. Commun. 12:6750-6750(2021).
//